Mirivadelgat is an investigational new drug that is being evaluated by Foresee Pharmaceuticals for the treatment of pulmonary arterial hypertension. It is an aldehyde dehydrogenase 2 activator.
The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.